Transatlantique Private Wealth’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,376
Closed -$270K 210
2025
Q3
$270K Sell
3,376
-2,693
-44% -$230K 0.09% 203
2025
Q2
$552K Sell
6,069
-2,102
-26% -$192K 0.2% 136
2025
Q1
$766K Buy
8,171
+1,777
+28% +$159K 0.31% 96
2024
Q4
$581K Sell
6,394
-95
-1% -$9.06K 0.22% 129
2024
Q3
$674K Sell
6,489
-1,662
-20% -$169K 0.26% 121
2024
Q2
$767K Sell
8,151
-67
-0.8% -$6.18K 0.31% 93
2024
Q1
$740K Buy
8,218
+15
+0.2% +$1.27K 0.32% 106
2023
Q4
$654K Buy
8,203
+168
+2% +$12.6K 0.3% 113
2023
Q3
$571K Buy
8,035
+41
+0.5% +$3.07K 0.31% 106
2023
Q2
$616K Buy
7,994
+164
+2% +$12.7K 0.32% 102
2023
Q1
$588K Buy
+7,830
New +$582K 0.33% 99

Other funds holding CL

Transatlantique Private Wealth's CL Position: Q4 2025 in Review

Transatlantique Private Wealth sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 3,376 shares — an estimated $270K sold.

Transatlantique Private Wealth first reported a position in CL in Q1 2023 and held it in 11 quarters. The position peaked at $767K in Q2 2024. 1,888 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • Transatlantique Private Wealth reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • Transatlantique Private Wealth sold 3,376 Colgate-Palmolive shares in Q4 2025, an estimated $270K.
  • Transatlantique Private Wealth first reported a position in Colgate-Palmolive in Q1 2023 and held it in 11 quarters.
  • Transatlantique Private Wealth's Colgate-Palmolive position peaked at $767K in Q2 2024.
  • 1,888 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.